インターロイキン‐17は重度の慢性自発性蕁麻疹における潜在的な関与者および治療ターゲットである

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria2014 · 170 citations
2. 2Th17 cell-mediated immune responses promote mast cell proliferation by triggering stem cell factor in keratinocytes2017 · 42 citations
3. 3Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis2018 · 42 citations
4. 4Human mast cells capture, store, and release bioactive, exogenous IL-17A2016 · 78 citations
5. 5Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria2018 · 103 citations